|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Sunday, June 22
by
All About MS
on Sun 22 Jun 2008 07:42 AM CST
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a cell therapy development and commercialization company, announced favourable safety and efficacy data for Tovaxin®, the Company's investigational T-cell vaccination more »
by
All About MS
on Sun 22 Jun 2008 01:00 AM CST
Evaluation of the patient with dizziness begins with careful history taking and complete physical examination, including vestibular examination. In the course of evaluating patients with vestibular and balance disorders, additional tests that are commonly more »
by
All About MS
on Sun 22 Jun 2008 12:00 AM CST
Peptimmune, Inc. a privately held biotechnology company, announced that physicians have treated the first participant in a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary more »
|
||